Orphan Drug Designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenström Macroglobulinemia. First-in-class Bruton’s tyrosine kinase (BT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback